elderly patients at high risk of triazolam-induced falls can be identified

1
Reactions 600 - 11 May 1996 Elderly patients at high risk of triazolam-induced falls can be identified by a high pretreatment level of postural sway, say US researchers. A placebo- controlled study in which 9 young (aged 20–29 years) and 9 older (aged 65–78 years) men received a single dose of triazolam 0.375mg demonstrated that the drug increased postural sway in both groups. However, the greater postural sway observed after drug administration in elderly people was related to higher baseline sway. There was no evidence that the pharmacokinetics of triazolam, or the level of responsiveness to the drug, was different in elderly volunteers, compared with younger volunteers. Robin DW, et al. Increased baseline sway contributes to increased losses of balance in older people following triazolam. Journal of the American Geriatrics Society 44: 300-304, Mar 1996 800432449 1 Reactions 11 May 1996 No. 600 0114-9954/10/0600-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

Upload: buimien

Post on 19-Mar-2017

212 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Elderly patients at high risk of triazolam-induced falls can be identified

Reactions 600 - 11 May 1996

■ Elderly patients at high risk of triazolam-inducedfalls can be identified by a high pretreatment level ofpostural sway, say US researchers. A placebo-controlled study in which 9 young (aged 20–29 years)and 9 older (aged 65–78 years) men received a singledose of triazolam 0.375mg demonstrated that the drugincreased postural sway in both groups. However, thegreater postural sway observed after drugadministration in elderly people was related to higherbaseline sway. There was no evidence that thepharmacokinetics of triazolam, or the level ofresponsiveness to the drug, was different in elderlyvolunteers, compared with younger volunteers.Robin DW, et al. Increased baseline sway contributes to increased losses ofbalance in older people following triazolam. Journal of the AmericanGeriatrics Society 44: 300-304, Mar 1996 800432449

1

Reactions 11 May 1996 No. 6000114-9954/10/0600-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved